Mitochondrial long chain fatty acid β-oxidation in man and mouse

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1791, Issue 8, 2009, Pages 806-815

  Chegary, Malika ^a   Brinke, Heleen te ^a   Ruiter, Jos P N ^a   Wijburg, Frits A ^a   Stoll, Maria S K ^b   Minkler, Paul E ^b   van Weeghel, Michel ^a   Schulz, Horst ^c   Hoppel, Charles L ^b   Wanders, Ronald J A ^a   Houten, Sander M ^a  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CITY COLLEGE OF NEW YORK   (United States)

Author keywords

Cellular metabolism; Fatty acid oxidation; Inborn errors of metabolism; Long chain acyl CoA dehydrogenase; Mouse model; Very long chain acyl CoA dehydrogenase

Indexed keywords

ACYLCARNITINE; LONG CHAIN ACYL COENZYME A DEHYDROGENASE; OLEIC ACID; VERY LONG CHAIN FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FATTY ACID OXIDATION; FIBROBLAST; HUMAN; HUMAN CELL; MALE; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACYL-COA DEHYDROGENASE, LONG-CHAIN; ANIMALS; CARNITINE; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FATTY ACIDS; FIBROBLASTS; HUMANS; MICE; MITOCHONDRIA; OXIDATION-REDUCTION; TANDEM MASS SPECTROMETRY;

MURINAE; MUS;

EID: 67650502781     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2009.05.006     Document Type: Article

References (40)

1. Rinaldo P., Matern D., and Bennett M.J. Fatty acid oxidation disorders. Annu. Rev. Physiol. 64 (2002) 477-502
2. Wanders R.J., Vreken P., den Boer M.E., Wijburg F.A., van Gennip A.H., and IJlst L. Disorders of mitochondrial fatty acyl-CoA beta-oxidation. J. Inherit. Metab. Dis. 22 (1999) 442-487
3. den Boer M.E., Wanders R.J., Morris A.A., IJlst L., Heymans H.S., and Wijburg F.A. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: clinical presentation and follow-up of 50 patients. Pediatrics 109 (2002) 99-104
4. Mathur A., Sims H.F., Gopalakrishnan D., Gibson B., Rinaldo P., Vockley J., Hug G., and Strauss A.W. Molecular heterogeneity in very-long-chain acyl-CoA dehydrogenase deficiency causing pediatric cardiomyopathy and sudden death. Circulation 99 (1999) 1337-1343
5. Saudubray J.M., Martin D., de Lonlay P., Touati G., Poggi-Travert F., Bonnet D., Jouvet P., Boutron M., Slama A., Vianey-Saban C., Bonnefont J.P., Rabier D., Kamoun P., and Brivet M. Recognition and management of fatty acid oxidation defects: a series of 107 patients. J. Inherit. Metab. Dis. 22 (1999) 488-502
6. Vianey-Saban C., Divry P., Brivet M., Nada M., Zabot M.T., Mathieu M., and Roe C. Mitochondrial very-long-chain acyl-coenzyme A dehydrogenase deficiency: clinical characteristics and diagnostic considerations in 30 patients. Clin. Chim. Acta 269 (1998) 43-62
7. Yamaguchi S., Indo Y., Coates P.M., Hashimoto T., and Tanaka K. Identification of very-long-chain acyl-CoA dehydrogenase deficiency in three patients previously diagnosed with long-chain acyl-CoA dehydrogenase deficiency. Pediatr. Res. 34 (1993) 111-113
8. Roe C.R., Sweetman L., Roe D.S., David F., and Brunengraber H. Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride. J. Clin. Invest. 110 (2002) 259-269
9. Roe C.R., Yang B.Z., Brunengraber H., Roe D.S., Wallace M., and Garritson B.K. Carnitine palmitoyltransferase II deficiency: successful anaplerotic diet therapy. Neurology 71 (2008) 260-264
10. Cox K.B., Hamm D.A., Millington D.S., Matern D., Vockley J., Rinaldo P., Pinkert C.A., Rhead W.J., Lindsey J.R., and Wood P.A. Gestational, pathologic and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and long-chain acyl-CoA dehydrogenase deficiency in the mouse. Hum. Mol. Genet. 10 (2001) 2069-2077
11. Exil V.J., Roberts R.L., Sims H., McLaughlin J.E., Malkin R.A., Gardner C.D., Ni G., Rottman J.N., and Strauss A.W. Very-long-chain acyl-coenzyme a dehydrogenase deficiency in mice. Circ. Res. 93 (2003) 448-455
12. Spiekerkoetter U., Tokunaga C., Wendel U., Mayatepek E., Exil V., Duran M., Wijburg F.A., Wanders R.J., and Strauss A.W. Changes in blood carnitine and acylcarnitine profiles of very long-chain acyl-CoA dehydrogenase-deficient mice subjected to stress. Eur. J. Clin. Invest. 34 (2004) 191-196
13. Exil V.J., Gardner C.D., Rottman J.N., Sims H., Bartelds B., Khuchua Z., Sindhal R., Ni G., and Strauss A.W. Abnormal mitochondrial bioenergetics and heart rate dysfunction in mice lacking very-long-chain acyl-CoA dehydrogenase. Am. J. Physiol. Heart Circ. Physiol. 290 (2006) H1289-H1297
14. Kurtz D.M., Rinaldo P., Rhead W.J., Tian L., Millington D.S., Vockley J., Hamm D.A., Brix A.E., Lindsey J.R., Pinkert C.A., O'Brien W.E., and Wood P.A. Targeted disruption of mouse long-chain acyl-CoA dehydrogenase gene reveals crucial roles for fatty acid oxidation. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 15592-15597
15. Ibdah J.A., Paul H., Zhao Y., Binford S., Salleng K., Cline M., Matern D., Bennett M.J., Rinaldo P., and Strauss A.W. Lack of mitochondrial trifunctional protein in mice causes neonatal hypoglycemia and sudden death. J. Clin. Invest. 107 (2001) 1403-1409
16. Ji S., You Y., Kerner J., Hoppel C.L., Schoeb T.R., Chick W.S., Hamm D.A., Sharer J.D., and Wood P.A. Homozygous carnitine palmitoyltransferase 1b (muscle isoform) deficiency is lethal in the mouse. Mol. Genet. Metab. 93 (2008) 314-322
17. Nyman L.R., Cox K.B., Hoppel C.L., Kerner J., Barnoski B.L., Hamm D.A., Tian L., Schoeb T.R., and Wood P.A. Homozygous carnitine palmitoyltransferase 1a (liver isoform) deficiency is lethal in the mouse. Mol. Genet. Metab. 86 (2005) 179-187
18. He X.Y., Shoukry K., Chu C., Yang J., Sprecher H., and Schulz H. Peroxisomes contain delta 3,5,delta 2,4-dienoyl-CoA isomerase and thus possess all enzymes required for the beta-oxidation of unsaturated fatty acids by a novel reductase-dependent pathway. Biochem. Biophys. Res. Commun. 215 (1995) 15-22
19. Rasmussen J.T., Borchers T., and Knudsen J. Comparison of the binding affinities of acyl-CoA-binding protein and fatty-acid-binding protein for long-chain acyl-CoA esters. Biochem. J. 265 (1990) 849-855
20. IJlst L., Mandel H., Oostheim W., Ruiter J.P., Gutman A., and Wanders R.J. Molecular basis of hepatic carnitine palmitoyltransferase I deficiency. J. Clin. Invest. 102 (1998) 527-531
21. van Vlies N., Ruiter J.P., Doolaard M., Wanders R.J., and Vaz F.M. An improved enzyme assay for carnitine palmitoyl transferase I in fibroblasts using tandem mass spectrometry. Mol. Genet. Metab. 90 (2007) 24-29
22. Ventura F.V., Costa C.G., Struys E.A., Ruiter J., Allers P., IJlst L., de Almeida I.T., Duran M., Jakobs C., and Wanders R.J. Quantitative acylcarnitine profiling in fibroblasts using [U-13C] palmitic acid: an improved tool for the diagnosis of fatty acid oxidation defects. Clin. Chim. Acta 281 (1999) 1-17
23. Minkler P.E., Ingalls S.T., and Hoppel C.L. Strategy for the isolation, derivatization, chromatographic separation, and detection of carnitine and acylcarnitines. Anal. Chem. 77 (2005) 1448-1457
24. Minkler P.E., Stoll M.S., Ingalls S.T., Yang S., Kerner J., and Hoppel C.L. Quantification of carnitine and acylcarnitines in biological matrices by HPLC electrospray ionization-mass spectrometry. Clin. Chem. 54 (2008) 1451-1462
25. Manning N.J., Olpin S.E., Pollitt R.J., and Webley J. A comparison of [9,10-3H]palmitic and [9,10-3H]myristic acids for the detection of defects of fatty acid oxidation in intact cultured fibroblasts. J. Inherit. Metab. Dis. 13 (1990) 58-68
26. Ramakers C., Ruijter J.M., Deprez R.H., and Moorman A.F. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci. Lett. 339 (2003) 62-66
27. Lehman T.C., Hale D.E., Bhala A., and Thorpe C. An acyl-coenzyme A dehydrogenase assay utilizing the ferricenium ion. Anal. Biochem. 186 (1990) 280-284
28. Furuta S., Miyazawa S., and Hashimoto T. Purification and properties of rat liver acyl-CoA dehydrogenases and electron transfer flavoprotein. J. Biochem. 90 (1981) 1739-1750
29. Dacremont G., and Vincent G. Assay of plasmalogens and polyunsaturated fatty acids (PUFA) in erythrocytes and fibroblasts. J. Inherit. Metab. Dis. 18 Suppl 1 (1995) 84-89
30. Onkenhout W., Venizelos V., van der Poel P.F., van den Heuvel M.P., and Poorthuis B.J. Identification and quantification of intermediates of unsaturated fatty acid metabolism in plasma of patients with fatty acid oxidation disorders. Clin. Chem. 41 (1995) 1467-1474
31. Aoyama T., Uchida Y., Kelley R.I., Marble M., Hofman K., Tonsgard J.H., Rhead W.J., and Hashimoto T. A novel disease with deficiency of mitochondrial very-long-chain acyl-CoA dehydrogenase. Biochem. Biophys. Res. Commun. 191 (1993) 1369-1372
32. Aoyama T., Souri M., Ushikubo S., Kamijo T., Yamaguchi S., Kelley R.I., Rhead W.J., Uetake K., Tanaka K., and Hashimoto T. Purification of human very-long-chain acyl-coenzyme A dehydrogenase and characterization of its deficiency in seven patients. J. Clin. Invest. 95 (1995) 2465-2473
33. Wanders R.J., Denis S., Ruiter J.P., IJlst L., and Dacremont G. 2,6-Dimethylheptanoyl-CoA is a specific substrate for long-chain acyl-CoA dehydrogenase (LCAD): evidence for a major role of LCAD in branched-chain fatty acid oxidation. Biochim. Biophys. Acta 1393 (1998) 35-40
34. Le W., Abbas A.S., Sprecher H., Vockley J., and Schulz H. Long-chain acyl-CoA dehydrogenase is a key enzyme in the mitochondrial beta-oxidation of unsaturated fatty acids. Biochim. Biophys. Acta 1485 (2000) 121-128
35. Yu W., Liang X., Ensenauer R.E., Vockley J., Sweetman L., and Schulz H. Leaky beta-oxidation of a trans-fatty acid: incomplete beta-oxidation of elaidic acid is due to the accumulation of 5-trans-tetradecenoyl-CoA and its hydrolysis and conversion to 5-trans-tetradecenoylcarnitine in the matrix of rat mitochondria. J. Biol. Chem. 279 (2004) 52160-52167
36. Roe D.S., Vianey-Saban C., Sharma S., Zabot M.T., and Roe C.R. Oxidation of unsaturated fatty acids by human fibroblasts with very-long-chain acyl-CoA dehydrogenase deficiency: aspects of substrate specificity and correlation with clinical phenotype. Clin. Chim. Acta 312 (2001) 55-67
37. He M., Rutledge S.L., Kelly D.R., Palmer C.A., Murdoch G., Majumder N., Nicholls R.D., Pei Z., Watkins P.A., and Vockley J. A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency. Am. J. Hum. Genet. 81 (2007) 87-103
38. Kurtz D.M., Tolwani R.J., and Wood P.A. Structural characterization of the mouse long-chain acyl-CoA dehydrogenase gene and 5′ regulatory region. Mamm. Genome 9 (1998) 361-365
39. Zhang Z., Zhou Y., Mendelsohn N.J., Bauer G.S., and Strauss A.W. Regulation of the human long chain acyl-CoA dehydrogenase gene by nuclear hormone receptor transcription factors. Biochim. Biophys. Acta 1350 (1997) 53-64
40. Ensenauer R., He M., Willard J.M., Goetzman E.S., Corydon T.J., Vandahl B.B., Mohsen A.W., Isaya G., and Vockley J. Human acyl-CoA dehydrogenase-9 plays a novel role in the mitochondrial beta-oxidation of unsaturated fatty acids. J. Biol. Chem. 280 (2005) 32309-32316